We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
INOV
101
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
| $44.2M | 0.07% |
2,296,863
+439,075
| +24% | +$7.79M |
|
102
Frontdoor
FTDR
$6.26B
| $44.1M | 0.07% |
994,815
+451,745
| +83% | +$18.4M |
|
103
Pacira BioSciences
PCRX
$997M
| $43.4M | 0.07% |
826,232
+71,236
| +9% | +$2.98M |
|
104
Ambev
ABEV
$46.4B
| $42.4M | 0.07% |
16,046,800
+9,900,584
| +161% | +$23.4M |
|
105
Repligen
RGEN
$9.25B
| $41.5M | 0.07% |
335,420
+29,131
| +10% | +$3.43M |
|
|
106
Bank of America Series L
BAC.PRL
$3.99B
| $41.3M | 0.07% |
1,738,480
+1,085,440
| +166% | +$1.47B |
|
107
Kornit Digital
KRNT
$791M
| $40.8M | 0.07% |
764,702
-52,293
| -6% | -$1.99M |
|
|
RP
108
DELISTED
RealPage, Inc.
RP
| $40.8M | 0.07% |
627,303
+54,425
| +10% | +$3.43M |
|
109
Rapid7
RPD
$773M
| $40.1M | 0.06% |
786,746
+68,414
| +10% | +$3.19M |
|
110
MACOM Technology Solutions
MTSI
$23.7B
| $39.5M | 0.06% |
1,151,171
+318,576
| +38% | +$9.31M |
|
|
MNTA
111
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $38.7M | 0.06% |
1,163,478
+235,063
| +25% | +$7.48M |
|
112
Advanced Drainage Systems
WMS
$10.9B
| $38.6M | 0.06% |
782,002
+67,803
| +9% | +$2.78M |
|
113
NeoGenomics
NEO
$2.13B
| $38.1M | 0.06% |
1,229,128
+106,650
| +10% | +$2.96M |
|
114
Halozyme
HALO
$12.2B
| $38.1M | 0.06% |
1,419,336
+123,333
| +10% | +$2.78M |
|
115
STAAR Surgical
STAA
$1.21B
| $38M | 0.06% |
617,523
+86,233
| +16% | +$3.52M |
|
116
National Vision
EYE
$1.81B
| $37.9M | 0.06% |
1,242,431
+220,635
| +22% | +$5.79M |
|
117
UFP Industries
UFPI
$5.19B
| $37.6M | 0.06% |
759,934
+231,116
| +44% | +$9.84M |
|
|
GLIBA
118
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $37.5M | 0.06% |
526,633
-24,021
| -4% | -$1.54M |
|
|
BKI
119
DELISTED
Black Knight, Inc. Common Stock
BKI
| $36M | 0.06% |
496,416
+25,982
| +6% | +$1.84M |
|
120
RBC Bearings
RBC
$18B
| $35.8M | 0.06% |
267,167
-67,587
| -20% | -$8.62M |
|
121
McGrath RentCorp
MGRC
$2.92B
| $35.7M | 0.06% |
661,322
+199,220
| +43% | +$10.7M |
|
122
Simply Good Foods
SMPL
$982M
| $35.7M | 0.06% |
1,919,772
+686,772
| +56% | +$12.2M |
|
123
Natera
NTRA
$46.4B
| $35.6M | 0.06% |
713,362
+61,881
| +9% | +$2.48M |
|
|
MIME
124
DELISTED
Mimecast Limited
MIME
| $35.5M | 0.06% |
852,615
+74,123
| +10% | +$2.91M |
|
125
TransUnion
TRU
$15.3B
| $35.1M | 0.06% |
403,843
+18,681
| +5% | +$1.49M |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.